| 标题 |
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024 |
| 网址 | |
| DOI |
10.1159/000533677
doi
|
| 其它 |
期刊:International Archives of Allergy and Immunology 作者:A. Sehgal; Peter A. Tauber; R. B. Stieger; B. Kratzer; Winfried F. Pickl 出版日期:2023-12-12 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)